1997
DOI: 10.1046/j.1537-2995.1997.37697335163.x
|View full text |Cite
|
Sign up to set email alerts
|

Infection with hepatitis G virus and its strain variant, the GB agent (GBV‐C), among blood donors in Japan

Abstract: More than 1 percent of Japanese blood donors were infected with HGV/GBV-C, and the prevalence was much higher in those with HCV RNA. Should persistent infection with HGV/GBV-C induce any hepatotoxic sequelae, either alone or in concert with the other hepatitis viruses, screening of blood units for HGV/GBV-C would deserve consideration.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
17
0

Year Published

1999
1999
2021
2021

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(20 citation statements)
references
References 24 publications
3
17
0
Order By: Relevance
“…This proportion correlated well with values previously reported for other geographic regions [1,8,10,[19][20][21]. Although GBV-C was mostly detected in the sera of blood donors with normal or modestly elevated ALT levels, it is not known if these donors are healthy carriers or patients at a quiescent stage of their disease.…”
Section: Discussionsupporting
confidence: 90%
“…This proportion correlated well with values previously reported for other geographic regions [1,8,10,[19][20][21]. Although GBV-C was mostly detected in the sera of blood donors with normal or modestly elevated ALT levels, it is not known if these donors are healthy carriers or patients at a quiescent stage of their disease.…”
Section: Discussionsupporting
confidence: 90%
“…The level of viraemia is also comparable to previous reports for blood donor populations in Scotland and elsewhere [Roth et al, 1997;Yoshikawa et al, 1997;Bjorkman et al, 1998;Blair et al, 1998;Love et al, 1999;Nordbo et al, 2000].…”
Section: Discussionsupporting
confidence: 90%
“…4 In Japan the prevalence is estimated at 1.1% in voluntary donors without any markers of HCV or HBV infection. 5 There are many factors and pathologic conditions known to cause liver dysfunction after BMT, including drug-related toxicity, hepatic veno-occlusive disease (VOD), GVHD and viral hepatitis, due to infection with cytomegalovirus, herpes simplex virus, varicella zoster, adenovirus, hepatitis C virus (HCV) and hepatitis B virus (HBV). This retrospective study was performed to investigate the influence of HGV infection on the post-transplant clinical course and liver function, assessed on serum levels of glutamic pyruvic transaminase (GPT; alanine amino transferase, ALT), in BMT patients.…”
mentioning
confidence: 99%